Product Program year 2023 Source: CMS Open Payments

Olympus

Device EndoTherapy

PDI 00821925042513

Open in the dashboard

General payments

$213,418

263 payments

Research payments

$0

0 payments

Through program year 2023, $213,418 in general payments and $0 in research payments were reported against Olympus (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $213,418 263

Breakdown

Who paid General payments · program year 2023
  1. Olympus Corporation of the Americas $209,954 247 payments
  2. Olympus America Inc. $3,464 16 payments
Top recipients General payments · program year 2023
  1. Alexander Chen Pulmonary Disease · Saint Louis, MO $54,497 26% · 59 payments
  2. Momen Wahidi Pulmonary Disease · Chicago, IL $36,493 17% · 42 payments
  3. Hans Lee Pulmonary Disease · Baltimore, MD $26,754 13% · 28 payments
  4. Angela Argento Pulmonary Disease · Baltimore, MD $26,308 12% · 25 payments
  5. Michael MacHuzak Pulmonary Disease · Cleveland, OH $24,420 11% · 20 payments

The top 5 of 60 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Pulmonary Disease Internal Medicine $194,392 93% · 30 practitioners
  2. Critical Care Medicine Internal Medicine $9,050 4% · 5 practitioners
  3. Internal Medicine $5,025 2% · 6 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $794 <1% · 2 practitioners
  5. Gastroenterology Internal Medicine $472 <1% · 4 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Missouri $54,894 26% · 2 recipients
  2. Maryland $53,529 25% · 5 recipients
  3. Illinois $36,932 17% · 4 recipients
  4. Ohio $25,611 12% · 4 recipients
  5. Texas $20,334 10% · 3 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

263 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record